NEW YORK (Reuters Health) – Imipenem-resistant Pseudomonas aeruginosa (IRPA) is an emerging problem and, in the ICU, patient-to-patient transmission may occur, even in the absence of an outbreak,…
NEW YORK (Reuters Health) – Treatment with fluvastatin both before and after vascular surgery decreases the incidence of cardiovascular death and myocardial infarction, according to results of a…
NEW YORK (Reuters Health) – New research suggests that fluoroquinolones may cause diplopia in some patients. “According to World Health Organization criteria, the relationship between fluoroquinolone therapy and…
NEW YORK (Reuters Health) – Adding dual antiplatelet therapy on top of existing anticoagulant therapy increases the bleeding risk after percutaneous coronary stenting, according to results from the…
Oliver Fein, MD, invites physicians to learn more information about Physicians for a National Health Program (PNHP)- an organization of which he is the President. Physicians for a…
Michael Banks, MD sits down with Oliver Fein, MD, President of Physicians for a National Health Program (PNHP), to discuss recent lobbying efforts surrounding the potential adoption of…
NEW YORK (Reuters Health) – Higher diastolic blood pressure is independently associated with impaired cognitive function in otherwise healthy middle-aged and older adults, new research suggests. Findings from…
NEW YORK (Reuters Health) – Nadroparin, a low-molecular-weight heparin, reduces the incidence of thromboembolic events in ambulatory patients receiving chemotherapy for metastatic or locally advanced solid cancers, an…
NEW YORK (Reuters Health) – In patients with high-risk acute coronary syndromes (ACS) without ST-segment elevation, delaying intervention until the next working day does not appear to pose…
NEW YORK (Reuters Health) – In patients with acute coronary syndromes (ACS), ticagrelor appears to be more effective than clopidogrel in reducing the incidence of death from vascular…
